Neuroimaging in Dementia

International Review of Neurobiology

Volumn 67, Issue , 2005, Pages 43-72

  Ebmeier, K P ^a   Donaghey, C ^a   Dougall, N J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; BRAIN MAPPING; CLASSIFICATION; DEMENTIA; DIAGNOSTIC IMAGING; HUMAN; METHODOLOGY; PATHOLOGY; REVIEW;

BRAIN; BRAIN MAPPING; DEMENTIA; DIAGNOSTIC IMAGING; HUMANS;

EID: 33646364595     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(05)67002-X     Document Type: Review

References (144)

1. Alexander G.E., Chen K., Pietrini P., Rapoport S.I., and Reiman E.M. Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential outcome measure in Alzheimer's disease treatment studies. Am. J. Psychiatry 159 (2002) 738-745
2. APA. "Diagnostic and statistical manual of mental disorders,". 4th edn. (1994), American Psychiatric Association, Washington, D.C
3. Backman L., Andersson J.L.R., Nyberg L., Winblad B., Nordberg A., and Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology 52 (1999) 1861
4. Backman L., Almkvist O., Andersson J., Nordberg A., Winblad B., Reineck R., and Langstrom A.B. Brain activation in young and older adults during implicit and explicit retrieval. J. Cogn. Neurosci. 9 (1997) 378-391
5. Bacskai B.J., Kajdasz S.T., Christie R.H., Carter C., Games D., Seubert P., Schenk D., and Hyman B.T. Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat. Med. 7 (2001) 369-372
6. Bacskai B.J., Hickey G.A., Skoch J., Kajdasz S.T., Wang Y., Huang G.F., Mathis C.A., Klunk W.E., and Hyman B.T. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-{beta} ligand in transgenic mice. Proc. Natl. Acad. Sci. 100 (2003) 12462-12467
7. Ballmaier M., O'Brien J.T., Burton E.J., Thompson P.M., Rex D.E., Narr K.L., McKeith I.G., DeLuca H., and Toga A.W. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: Diagnosis and gender effects. Neuroimage 23 (2004) 325-335
8. Barber R., Ballard C., McKeith I.G., Gholkar A., and O'Brien J.T. MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia. Neurology 54 (2000) 1304-1309
9. Barber R., Scheltens P., Gholkar A., Ballard C., McKeith I., Ince P., Perry R., and O'Brien J. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J. Neurol. Neurosurg. Psychiatry 67 (1999) 66-72
10. Baron J.C., Chetelat G., Desgranges B., Perchey G., Landeau B., de la Sayette V., and Eustache F. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 14 (2001) 298-309
11. Battistin L., Pizzolato G., Dam M., Ponza I., Borsato N., Zanco P.L., and Ferlin G. Regional cerebral blood flow study with 99mTc-hexamethyl-propyleneamine oxime single photon emission computed tomography in Alzheimer's and multi-infarct dementia. Eur. Neurol. 30 (1990) 296-301
12. Bench C.J., Frith C.D., Grasby P.M., Friston K.J., Paulesu E., Frackowiak R.S.J., and Dolan R.J. Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia 31 (1993) 907-922
13. Benson D.F., Kuhl D.E., Hawkins R.A., Phelps M.E., Cummings J.L., and Tsai S.Y. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch. Neurol. 40 (1983) 711-714
14. Bonte F.J., Harris T.S., Roney C.A., and Hynan L.S. Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign. J. Nucl. Med. 45 (2004) 771-774
15. Bonte F.J., Weiner M.F., Bigio E.H., and White C.L. Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients. Radiology 202 (1997) 793-797
16. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., and Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 343 (2000) 450-456
17. Bowen B., Barker W.W., Loewenstein D.A., Sheldon J., and Duara R. MR signal abnormalities in memory disorder and dementia. AJR Am. J. Roentgenol. 154 (1990) 1285-1292
18. Bradley K.M., Sullivan V.T., Soper N.D., Nagy Z., King E.M., Smith A.D., and Shepstone B.J. Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease. Brain 125 (2002) 1772-1781
19. Braffman B., Drayer B.P., Anderson R.E., Davis P.C., Deck M.D., Hasso A.N., Johnson B.A., Masaryk T., Pomeranz S.J., Seidenwurm D., Tanenbaum L., and Masdeu J.C. Dementia. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl (2000) 525-533
20. Broytman O., and Malter J.S. Anti-Abeta: The good, the bad, and the unforeseen. J. Neurosci. Res. 75 (2004) 301-306
21. Burdette J.H., Minoshima S., Vander Borght T., Tran D.D., and Kuhl D.E. Alzheimer's disease: Improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology 198 (1996) 837-843
22. Butler R.E., Costa D.C., Greco A., Ell P.J., and Katona C.L.E. Differentiation between Alzheimer's disease and multi-infarct dementia: SPECT vs MR imaging. Int. J. Geriatr. Psychiatry 10 (1995) 121-128
23. Cabeza R., and Nyberg L. Imaging cognition: An empirical review of PET studies with normal subjects. J. Cogn. Neurosci. 9 (1997) 1-26
24. Cabeza R., and Nyberg L. Imaging cognition II: An empirical review of 275 PET and fMRI studies. J. Cogn. Neurosci. 12 (2000) 1-47
25. Callen D.J.A., Black S.E., and Caldwell C.B. Limbic system perfusion in Alzheimer's disease measured by MRI-coregistered HMPAO SPET. Eur. J. Nucl. Med. Mol. Imaging 29 (2002) 899-906
26. Carter C.S., Mintun M., and Cohen J.D. Interference and facilitation effects during selective attention: An H215O PET Study of Stroop Task Performance. Neuroimage 2 (1995) 264-272
27. Claus J.J., Dubois E.A., Booij J., Habraken J., de Munck J.C., van Herk M., Verbeeten Jr. B., and van Royen E.A. Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography. Eur. J. Nucl. Med. 24 (1997) 602-608
28. Courtney C., Farrell D., Gray R., Hills R., Lynch L., Sellwood E., Edwards S., Hardyman W., Raftery J., Crome P., Lendon C., Shaw H., and Bentham P. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial. Lancet 363 (2004) 2105-2115
29. D'Esposito M., Aguirre G.K., Zarahn E., Ballard D., Shin R.K., and Lease J. Functional MRI studies of spatial and nonspatial working memory. Cogn. Brain Res. 7 (1998) 1-13
30. Dawson M.R., Dobbs A., Hooper H.R., McEwan A.J., Triscott J., and Cooney J. Artificial neural networks that use single-photon emission tomography to identify patients with probable Alzheimer's disease. Eur. J. Nucl. Med. 21 (1994) 1303-1311
31. De Santi S., de Leon M.J., Rusinek H., Convit A., Tarshish C.Y., Roche A., Tsui W.H., Kandil E., Boppana M., Daisley K., Wang G.J., Schlyer D., and Fowler J. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol. Aging 22 (2001) 529-539
32. deFigueiredo R.J., Shankle W.R., Maccato A., Dick M.B., Mundkur P., Mena I., and Cotman C.W. Neural-network-based classification of cognitively normal, demented, Alzheimer's disease and vascular dementia from single photon emission with computed tomography image data from brain. Proc. Natl. Acad. Sci. USA 92 (1995) 5530-5534
33. Desgranges B., Baron J.C., de la Sayette V., Petit-Taboue M.C., Benali K., Landeau B., Lechevalier B., and Eustache F. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain 121 (1998) 611-631
34. Desgranges B., Baron J.C., Lalevee C., Giffard B., Viader F., de la Sayette V., and Eustache F. The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: Relationship to degree of deterioration. Brain 125 (2002) 1116-1124
35. Diehl J., Grimmer T., Drzezga A., Riemenschneider M., Forstl H., and Kurz A. Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study. Neurobiol. Aging 25 (2004) 1051-1056
36. Dougall N.J., Bruggink S., and Ebmeier K.P. A systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am. J. Geriatr. Psychiatry 12 (2004) 554-570
37. El Fakhri G., Kijewski M.F., Johnson K.A., Syrkin G., Killiany R.J., Becker J.A., Zimmerman R.E., and Albert M.S. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. Arch. Neurol. 60 (2003) 1066-1072
38. Elgh E., Sundstrom T., Nasman B., Ahlstrom R., and Nyberg L. Memory functions and rCBF (99m)Tc-HMPAO SPET: Developing diagnostics in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 29 (2002) 1140-1148
39. Erkinjuntti T., Lee D.H., Gao F.Q., Steenhuis R., Eliasziw M., Fry R., Merskey H., and Hachinski V.C. Temporal-lobe atrophy on magnetic-resonance-imaging in the diagnosis of early Alzheimers-disease. Arch. Neurol. 50 (1993) 305-310
40. Frackowiak R.S.J., Pozzilli C., Legg N.J., Du Boulay G.H., Marshall J., Lenzi G.L., and Jones T. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron emission tomography. Brain 104 (1981) 753-758
41. Friedland R.P., Kalaria R., Berridge M., Miraldi F., Hedera P., Reno J., Lyle L., and Marotta C.A. Neuroimaging of vessel amyloid in Alzheimer's disease. Ann. NY Acad. Sci. 826 (1997) 242-247
42. Friston K.J., Holmes A.P., Worsley K.J., Poline J.-P., Frith C.D., and Frackowiak R.S.J. Statistical parametric maps in functional imaging: A general linear approach. Hum. Brain Mapping 2 (1995) 189-210
43. Geddes J.W., Tekirian T.L., Soultanian N.S., Ashford J.W., Davis D.G., and Markesbery W.R. Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease. Neurobiol. Aging 18 (1997) 99-105
44. Gill S.S., Rochon P.A., Guttman M., and Laupacis A. The value of positron emission tomography in the clinical evaluation of dementia. J. Am. Geriatr. Soc. 51 (2003) 258-264
45. Goldberg T.E., Berman K.F., Fleming K., Ostrem J., Van Horn J.D., Esposito G., Mattay V.S., Gold J.M., and Weinberger D.R. Uncoupling cognitive workload and prefrontal cortical physiology: A PET rCBF study. Neuroimage 7 (1998) 296-303
46. Grady C.L. Functional brain imaging and age-related changes in cognition. Biol. Psychol. 54 (2000) 259-281
47. Hachinski V.C., Iliff L.D., Zilhka E., Du Boulay G.H., McAllister V.L., Marshall J., Russell R.W., and Symon L. Cerebral blood flow in dementia. Arch. Neurol. 32 (1975) 632-637
48. Hanyu H., Shimuzu T., Tanaka Y., Takasaki M., Koizumi K., and Abe K. Effect of age on regional cerebral blood flow patterns in Alzheimer's disease patients. J. Neurol. Sci. 209 (2003) 25-30
49. Herholz K. PET studies in dementia. Ann. Nucl. Med. 17 (2003) 79-89
50. Herholz K., Nordberg A., Salmon E., Perani D., Kessler J., Mielke R., Halber M., Jelic V., Almkvist O., Collette F., Alberoni M., Kennedy A., Hasselbalch S., Fazio F., and Heiss W.D. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia Geriatr. Cogn. Disord. 10 (1999) 494-504
51. Herholz K., Schopphoff H., Schmidt M., Mielke R., Eschner W., Scheidhauer K., Schicha H., Heiss W.D., and Ebmeier K. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease. J. Nucl. Med. 43 (2002) 21-26
52. Hirono N., Mori E., Ishii K., Imamura T., Tanimukai S., Kazui H., Hashimoto M., Takatsuki Y., Kitagaki H., and Sasaki M. Neuronal substrates for semantic memory: A positron emission tomography study in Alzheimer's disease. Dementia Geriatr. Cogn. Disord. 12 (2001) 15-21
53. Hoffman J.M., Welsh-Bohmer K.A., Hanson M., Crain B., Hulette C., Earl N., and Coleman R.E. FDG PET imaging in patients with pathologically verified dementia. J. Nucl. Med. 41 (2000) 1920-1928
54. Honda N., Machida K., Matsumoto T., Matsuda H., Imabayashi E., Hashimoto J., Hosono M., Inoue Y., Koizumi K., Kosuda S., Momose T., and Mori Y. Three-dimensional stereotactic surface projection of brain perfusion SPECT improves diagnosis of Alzheimer's disease. Ann. Nucl. Med. 17 (2003) 641-648
55. Huang C., Wahlund L.O., Svensson L., Winblad B., and Julin P. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC Neurol. 2 (2002) 9
56. Ibanez V., Pietrini P., Alexander G.E., Furey M.L., Teichberg D., Rajapakse J.C., Rapoport S.I., Schapiro M.B., and Horwitz B. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50 (1998) 1585-1593
57. Imamura T., Ishii K., Hirono N., Hashimoto M., Tanimukai S., Kazui H., Hanihara T., Sasaki M., and Mori E. Occipital glucose metabolism in dementia with Lewy bodies with and without Parkinsonism: A study using positron emission tomography. Dementia Geriatr. Cogn. Disord. 12 (2001) 194-197
58. Ishii K., Sakamoto S., Sasaki M., Kitagaki H., Yamaji S., Hashimoto M., Imamura T., Shimomura T., Hirono N., and Mori E. Cerebral glucose metabolism in patients with frontotemporal dementia. J. Nucl. Med. 39 (1998) 1875-1878
59. Ishii K., Yamaji S., Kitagaki H., Imamura T., Hirono N., and Mori E. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 53 (1999) 413-416
60. Jack C.R., Petersen R.C., Xu Y.C., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Waring S.C., Tangalos E.G., and Kokmen E. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52 (1999) 1397-1403
61. Jagust W., Thisted R., Devous M.D., Van Heertum R., Mayberg H., Jobst K., Smith A.D., and Borys N. SPECT perfusion imaging in the diagnosis of Alzheimer's disease-a clinical-pathologic study. Neurology 56 (2001) 950-956
62. Jagust W. Molecular neuroimaging in Alzheimer's disease. NeuroRx 1 (2004) 206-212
63. Jobst K.A., Smith A.D., Barker C.S., Wear A., King E.M., Smith A., Anslow P.A., Molyneux A.J., Shepstone B.J., Soper N., Holmes K.A., Robinson J.R., Hope R.A., Oppenheimer C., Brockbank K., and McDonald B. Association of atrophy of the medial temporal-lobe with reduced blood-flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimers-disease. J. Neurol. Neurosurg. Psychiatry 55 (1992) 190-194
64. Kaneko K., Kuwabara Y., Sasaki M., Ogomori K., Ichimiya A., Koga H., Nakagawa M., Hayashi K., and Honda H. Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT. Clin. Nucl. Med. 29 (2004) 362-366
65. Kanetaka H., Matsuda H., Ohnishi T., Asada T., Yamashita N., Nakano S., Imabayashi E., and Tanaka F. Correction for partial volume effects elevates diagnostic performance of very early Alzheimer's disease in brain perfusion SPECT. J. Nucl. Med. 44 (2003) 830
66. Kemp P.M., Holmes C., Hoffmann S.M., Bolt L., Holmes R., Rowden J., and Fleming J.S. Alzheimer's disease: Differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia. J. Neurol. Neurosurg. Psychiatry 74 (2003) 715-719
67. Kesslak J.P., Nalcioglu O., and Cotman C.W. Quantification of magnetic-resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's-disease. Neurology 41 (1991) 51-54
68. Killiany R.J., Moss M.B., Albert M.S., Sandor T., Tieman J., and Jolesz F. Temporal-lobe regions on magnetic-resonance-imaging identify patients with early Alzheimer's-disease. Arch. Neurol. 50 (1993) 949-954
69. Kippenhan J.S., Barker W.W., Nagel J., Grady C., and Duara R. Neural-network classification of normal and Alzheimer's disease subjects using high-resolution and low-resolution PET cameras. J. Nucl. Med. 35 (1994) 7-15
70. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomquist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., and Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55 (2004) 306-319
71. Knopman D.S., De Kosky S.T., Cummings J.L., Chui H., Corey-Bloom J., Relkin N., Small G.W., Miller B., and Stevens J.C. Practice parameter: Diagnosis of dementia (an evidence-based review)-Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56 (2001) 1143-1153
72. Kogure D., Matsuda H., Ohnishi T., Asada T., Uno M., Kunihiro T., Nakano S., and Takasaki M. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J. Nucl. Med. 41 (2000) 1155-1162
73. Kozachuk W., De Carli C., Schapiro M.B., Wagner E., Rapoport S.I., and Horwitz B. White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. Arch. Neurol. 47 (1990) 1306-1310
74. Kulasingam S.L., Samsa G.P., Zarin D.A., Rutschmann O.T., Patwardhan M.B., McCrory D.C., Schmechel D.E., and Matchar D.B. When should functional neuroimaging techniques be used in the diagnosis and management of Alzheimer's dementia? A decision analysis. Value Health 6 (2003) 542-550
75. Launes J., Sulkava R., Erkinjuntti T., Nikkinen P., Lindroth L., Liewendahl K., and Iivanainen M. 99Tcm-HMPAO SPECT in suspected dementia. Nucl. Med. Commun. 12 (1991) 757-765
76. Lechner H., and Bertha G. Multiinfarct dementia. J. Neural. Transm. Suppl. 33 (1991) 49-52
77. Lee B.F., Liu C.K., Tai C.T., Chiu N.T., Liu G.C., Yu H.S., and Pai M.C. Alzheimer's disease: Scintigraphic appearance of Tc-99m HMPAO brain spect. Kaohsiung J. Med. Sci. 17 (2001) 394-400
78. Lee Y.C., Liu R.S., Liao Y.C., Sun C.M., Wang P.S., Wang P.N., and Liu H.C. Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease. Eur. Neurol. 49 (2003) 142-145
79. Lezak M. "Neuropsychological assessment,". 2nd ed. (1983), Oxford University Press, New York
80. Lezak M. "Neuropsychological assessment,". 3rd ed. (1995), Oxford University Press, New York
81. Lobotesis K., Fenwick J.D., Phipps A., Ryman A., Swann A., Ballard C., McKeith I.G., and Brien J.T. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 56 (2001) 643-649
82. Mahony D., Coffey J., Murphy J., Hare N., Hamilton D., Freyne P., Walsh J.B., and Coakley D. The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. J. Nucl. Med. 35 (1994) 1450-1455
83. Masterman D.L., Mendez M.F., Fairbanks L.A., and Cummings J.L. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias. J. Geriatr. Psychiatry Neurol. 10 (1997) 15-21
84. 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J. Med. Chem. 46 (2003) 2740-2754
85. Mathis C.A., Bacskai B.J., Kajdasz S.T., McLellan M.E., Frosch M.P., Hyman B.T., Holt D.P., Wang Y., Huang G.F., Debnath M.L., and Klunk W.E. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorgan. Med. Chem. Lett. 12 (2002) 295-298
86. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., and Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1114
87. Melendez J.C., and McCrank E. Anxiety-related reactions associated with magnetic resonance imaging examinations. JAMA 270 (1993) 745-747
88. Meltzer C.C., Zubieta J.K., Brandt J., Tune L.E., Mayberg H.S., and Frost J.J. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 47 (1996) 454-461
89. Mentis M.J., Horwitz B., Grady C.L., Alexander G.E., VanMeter J.W., Maisog J.M., Pietrini P., Schapiro M.B., and Rapoport S.I. Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. Am. J. Psychiatry 153 (1996) 32-40
90. Messa C., Perani D., Lucignani G., Zenorini A., Zito F., Rizzo G., Grassi F., Delsole A., Franceschi M., Gilardi M.C., and Fazio F. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimers-disease-comparison with fluorine-18-FDG PET. J. Nucl. Med. 35 (1994) 210-216
91. Mielke R., and Heiss W.D. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia. J. Neural Transm. Suppl. 53 (1998) 237-250
92. Mielke R., Herholz K., Grond M., Kessler J., and Heiss W.D. Differences of regional cerebral glucose-metabolism between presenile and senile dementia of Alzheimer type. Neurobiol. Aging 13 (1992) 93-98
93. Minoshima S., Foster N.L., Sima A.A.F., Frey K.A., Albin R.L., and Kuhl D.E. Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation. Ann. Neurol. 50 (2001) 358-365
94. Minoshima S., Giordani B., Berent S., Frey K.A., Foster N.L., and Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42 (1997) 85-94
95. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., and Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
96. Mummery C.J., Patterson K., Wise R.J.S., Vandenbergh R., Price C.J., and Hodges J.R. Disrupted temporal lobe connections in semantic dementia. Brain 122 (1999) 61-73
97. Murphy D.G.M., De Carli C., McIntosh A.R., Daly E., Mentis M.J., Pietrini P., Szczepanik J., Schapiro M.B., Grady C.L., Horwitz B., and Rapoport S.I. Sex differences in human brain morphometry and metabolism: An in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch. Gen. Psychiatry 53 (1996) 585-594
98. Nagata K., Maruya H., Yuya H., Terashi H., Mito Y., Kato H., Sato M., Satoh Y., Watahiki Y., Hirata Y., Yokoyama E., and Hatazawa J. Can PET data differentiate Alzheimer's disease from vascular dementia?. Ann. NY Acad. Sci. 903 (2000) 252-261
99. Nestor P.J., Fryer T.D., Ikeda M., and Hodges J.R. Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease). Eur. J. Neurosci. 18 (2003) 2663-2667
100. Nestor P.J., Scheltens P., and Hodges J.R. Advances in the early detection of Alzheimer's disease. Nat. Rev. Neurosci. 5 Suppl (2004) S34-S41
101. Nitrini R., Buchpiguel C.A., Caramelli P., Bahia V.S., Mathias S.C., Nascimento C.M.R., Degenszajn J., and Caixeta L. SPECT in Alzheimer's disease: Features associated with bilateral parietotemporal hypoperfusion. Acta Neurol. Scand. 101 (2000) 172-176
102. Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease: Therapeutic implications. Biol. Psychiatry 49 (2001) 200-210
103. Nordberg A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol 3 (2004) 519-527
104. O'Brien J.T., Ames D., Desmond P., Lichtenstein M., Binns D., Schweitzer I., Davis S., and Tress B. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls. Int. Psychogeriatr. 13 (2001) 149-161
105. O'Brien J.T., Colloby S., Fenwick J., Williams E.D., Firbank M., Burn D., Aarsland D., and McKeith I.G. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch. Neurol. 61 (2004) 919-925
106. OBrien J.T., Desmond P., Ames D., Schweitzer I., Chiu E., and Tress B. Temporal lobe magnetic resonance Imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment. Psychol. Med. 27 (1997) 1267-1275
107. Okamura N., Arai H., Higuchi M., Tashiro M., Matsui T., Hu X.S., Takeda A., Itoh M., and Sasaki H. [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 25 (2001) 447-456
108. Ott B.R., Heindel W.C., Tan Z., and Noto R.B. Lateralized cortical perfusion in women with Alzheimer's disease. J. Gend. Specif. Med. 3 (2000) 29-35
109. Pagani M., Salmaso D., Ramstrom C., Jonsson C., Lundqvist R., Thurfjell L., Schnell P.O., Wagner A., Jacobsson H., and Larsson S.A. Mapping pathological Tc-99m-d, I-hexamethylpropylene amine oxime uptake in Alzheimer's disease and frontal lobe dementia with SPECT. Dementia Geriatr. Cogn. Disord. 12 (2001) 177-184
110. Patterson C.J., Gauthier S., Bergman H., Cohen C.A., Feightner J.W., Feldman H., and Hogan D.B. The recognition, assessment and management of dementing disorders: Conclusions from the Canadian Consensus Conference on Dementia. CMAJ 160 (1999) S1-S15
111. Patwardhan M.B., McCrory D.C., Matchar D.B., Samsa G.P., and Rutschmann O.T. Alzheimer disease: Operating characteristics of PET-a meta-analysis. Radiology 231 (2004) 73-80
112. Perry E.K., Tomlinson B.E., Blessed G., Bergmann L., Gibson P.H., and Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 2 (1978) 1457-1459
113. Perry R.J., Watson P., and Hodges J.R. The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: Relationship to episodic and semantic memory impairment. Neuropsychologia 38 (2000) 252-271
114. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., and Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 58 (2001) 1985-1992
115. Pickut B.A., Saerens J., Marien P., Borggreve F., Goeman J., Vandevivere J., Vervaet A., Dierckx R., and de Deyn P.P. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type. J. Nucl. Med. 38 (1997) 929-934
116. Poduslo J.F., Wengenack T.M., Curran G.L., Wisniewski T., Sigurdsson E.M., Macura S.I., Borowski B.J., and Jack J. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol. Dis. 11 (2002) 315-329
117. Prvulovic D., Hubl D., Sack A.T., Melillo L., Maurer K., Frolich L., Lanfermann H., Zanella F.E., Goebel R., Linden D.E.J., and Dierks T. Functional imaging of visuospatial processing in Alzheimer's disease. Neuroimage 17 (2002) 1403-1414
118. Read S.L., Miller B.L., Mena I., Kim I.M.R., Itabashi H., and Darby A. SPECT indementia: Clinical and pathological correlation. J. Am. Geriatr. Soc. 43 (1995) 1243-1247
119. Reisberg B., Burns A., Brodaty H., Eastwood R., Rossor M., Sartorius N., and Winblad B. Diagnosis of Alzheimer's disease. Report of an International Psychogeriatric Association Special Meeting Work Group under the cosponsorship of Alzheimer's Disease International, the European Federation of Neurological Societies, the World Health Organization, and the World Psychiatric Association. Int. Psychogeriatr. 9 Suppl. 1 (1997) 11-38
120. Ritchie C.W., Ames D., Clayton T., and Lai R. Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease. Am. J. Geriatr. Psychiatry 12 (2004) 358-369
121. Robinson S.R., Bishop G.M., Lee H.G., and Munch G. Lessons from the AN 1792 Alzheimer vaccine: Lest we forget. Neurobiol. Aging 25 (2004) 609-615
122. Rossor M.N., Kennedy A.M., and Frackowiak R.S.J. Clinical and neuroimaging features of familial Alzheimer's disease. Neurobiol. Alzheimer's Dis. 777 (1996) 49-56
123. Salmon E., Collette F., Degueldre C., Lemaire C., and Franck G. Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease. Hum. Brain Map. 10 (2000) 39-48
124. Shoghi-Jadid K., Small G.W., Agdeppa E.D., Kepe V., Ercoli L.M., Siddarth P., Read S., Satyamurthy N., Petric A., Huang S.C., and Barrio J.R. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am. J. Geriatr. Psychiatry 10 (2002) 24-35
125. Silverman D.H.S., Small G.W., Chang C.Y., Lu C.S., de Aburto M.A.K., Chen W., Czernin J., Rapoport S.I., Pietrini P., Alexander G.E., Schapiro M.B., Jagust W.J., Hoffman J.M., Welsh-Bohmer K.A., Alavi A., Clark C.M., Salmon E., de Leon M.J., Mielke R., Cummings J.L., Kowell A.P., Gambhir S.S., Hoh C.K., and Phelps M.E. Positron emission tomography in evaluation of dementia-regional brain metabolism and long-term outcome. JAMA 286 (2001) 2120-2127
126. Sjogren M., Gustafson L., Wikkelso C., and Wallin A. Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio. Dementia Geriatr. Cogn. Disord. 11 (2000) 275-285
127. Smith C.D., Andersen A.H., Kryscio R.J., Schmitt F.A., Kindy M.S., Blonder L.X., and Avison M.J. Women at risk for AD show increased parietal activation during a fluency task. Neurology 58 (2002) 1197-1202
128. Soonawala D., Amin T., Ebmeier K.P., Steele J.D., Dougall N.J., Best J., Migneco O., Nobili F., and Scheidhauer K. Statistical parametric mapping of 99mTc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: Normalizing to cerebellar tracer uptake. Neuroimage 17 (2002) 1193-1202
129. Starkstein S.E., Sabe L., Vazquez S., Teson A., Petracca G., Chemerinski E., Di L., and Leiguarda R. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke 27 (1996) 408-414
130. Stein D.J., Buchsbaum M.S., Hof P.R., Siegel B.V., and Shihabuddin L. Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's disease. Neuropsychobiology 37 (1998) 10-19
131. Strange B.A., Fletcher P.C., Henson R.N., Friston K.J., and Dolan R.J. Segregating the functions of human hippocampus. Proc. Natl. Acad. Sci. USA 96 (1999) 4034-4039
132. Thompson S.A., Graham K.S., Patterson K., Sahakian B.J., and Hodges J.R. Is knowledge of famous people disproportionately impaired in patients with early and questionable Alzheimer's disease?. Neuropsychology 16 (2002) 344-358
133. Trollor J.N., and Valenzuela M.J. Brain ageing in the new millennium. Aust. N Z J. Psychiatry 35 (2001) 788-805
134. Varma A.R., Adams W., Lloyd J.J., Carson K.J., Snowden J.S., Testa H.J., Jackson A., and Neary D. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. Acta Neurologica Scand. 105 (2002) 261-269
135. Villa G., Cappa A., Tavolozza M., Gainotti G., Giordano A., Calcagni M.L., and De Rossi G. Neuropsychological tests and [99mTc]-HM PAO SPECT in the diagnosis of Alzheimer's dementia. J. Neurol. 242 (1995) 359-366
136. Volkow N.D., Zhu W., Felder C.A., Mueller K., Welsh T.F., Wang G.J., and de Leon M.J. Changes in brain functional homogeneity in subjects with Alzheimer's disease. Psychiatry Res. Neuroimaging 114 (2002) 39-50
137. Wadghiri Y.Z., Sigurdsson E.M., Sadowski M., Elliott J.I., Li Y., Scholtzova H., Tang C.Y., Aguinaldo G., Pappolla M., Duff K., Wisniewski T., and Turnbull D.H. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn. Resonan. Med. 50 (2003) 293-302
138. Walker Z., Costa D.C., Walker R.W., Lee L., Livingston G., Jaros E., Perry R., McKeith I., and Katona C.L. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison. Neurology 62 (2004) 1568-1572
139. Weinberger D.R., Gibson R., Coppola R., Jones D.W., Molchan S., Sunderland T., Berman K.F., and Reba R.C. The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography. Arch. Neurol. 48 (1991) 169-176
140. Wilcock G.K., Hope R.A., Brooks D.N., Lantos P.L., Oppenheimer C., Reynolds G.P., Rossor M.N., and Davies M.B. Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee. J. Neurol. Neurosurg. Psychiatry 52 (1989) 693-700
141. Wyper D.J., Brown D., Patterson J., Owens J., Hunter R., Teasdale E., and McCulloch J. Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease. Eur. J. Nucl. Med. 20 (1993) 379-386
142. Yoshikawa T., Murase K., Oku N., Kitagawa K., Imaizumi M., Takasawa M., Nishikawa T., Matsumoto M., Hatazawa J., and Hori M. Statistical image analysis of cerebral blood flow in vascular dementia with small-vessel disease. J. Nucl. Med. 44 (2003) 505-511
143. Zakzanis K.K., Graham S.J., and Campbell Z. A meta-analysis of
144. Zekry D., Duyckaerts C., Belmin J., Geoffre C., Moulias R., and Hauw J.J. Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology. J. Neurol. 249 (2002) 1529-1534